BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10376972)

  • 1. Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232.
    Diaconu CC; Szathmári M; Kéri G; Venetianer A
    Br J Cancer; 1999 Jun; 80(8):1197-203. PubMed ID: 10376972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
    Fantappiè O; Solazzo M; Lasagna N; Platini F; Tessitore L; Mazzanti R
    Cancer Res; 2007 May; 67(10):4915-23. PubMed ID: 17510421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway.
    Zhang H; Ozaki I; Mizuta T; Matsuhashi S; Yoshimura T; Hisatomi A; Tadano J; Sakai T; Yamamoto K
    Cancer; 2002 Aug; 95(4):896-906. PubMed ID: 12209735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
    Kubo K; Matsuzaki Y; Kato A; Terai S; Okita K
    Int J Oncol; 1999 Jan; 14(1):41-6. PubMed ID: 9863007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines.
    Rahman MA; Dhar DK; Masunaga R; Yamanoi A; Kohno H; Nagasue N
    Cancer Res; 2000 Apr; 60(8):2085-9. PubMed ID: 10786664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative efficacy of the somatostatin analogue TT-232 in human melanoma cells and tumours.
    Schwab RE; Froidevaux S; Paku S; Tejeda M; Szende B; Pap A; Beglinger C; Eberle AN; Kéri G
    Anticancer Res; 2001; 21(1A):71-5. PubMed ID: 11299792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.
    Miao J; Chen GG; Chun SY; Chak EC; Lai PB
    Int J Oncol; 2004 Sep; 25(3):651-9. PubMed ID: 15289866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
    Okamura M; Hashimoto K; Shimada J; Sakagami H
    Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
    Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
    Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
    Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
    Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
    Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of a cisplatin-induced resistant human hepatocellular carcinoma cell model and preliminary study on its resistant mechanisms].
    Yang J; Tang W
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):464-5. PubMed ID: 12502457
    [No Abstract]   [Full Text] [Related]  

  • 16. The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.
    Tejeda M; Gaal D; Barna K; Csuka O; Kéri G
    Anticancer Res; 2003; 23(5A):4061-6. PubMed ID: 14666719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
    Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
    Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure].
    Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):95-8. PubMed ID: 14980111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.
    Scheltema JM; Romijn JC; van Steenbrugge GJ; Schröder FH; Mickisch GH
    Anticancer Res; 2001; 21(5):3161-6. PubMed ID: 11848468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.